Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas

Oncotarget

Volumn 7, Issue 26, 2016, Pages 39241-39255

  Adams, Olivia ^a   Dislich, Bastian ^a   Berezowska, Sabina ^a   Schläfli, Anna M ^a   Seiler, Christian A ^b   Kroell, Dino ^b   Tschan, Mario P ^a   Langer, Rupert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Autophagy; Esophageal adenocarcinoma; LC3B; P62; Pathology section

Indexed keywords

CHLOROQUINE; LIGHT CHAIN 3 B PROTEIN; PROTEIN P62; TUMOR MARKER; UNCLASSIFIED DRUG; MAP1LC3B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYSOSOME; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ADENOCARCINOMA; CHEMISTRY; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AUTOPHAGY; BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYSOSOMES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; RNA-BINDING PROTEINS; TREATMENT OUTCOME;

EID: 84982065990     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9649     Document Type: Article

References (39)

1. Napier KJ, Scheerer M and Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World journal of gastrointestinal oncology. 2014; 6:112-120.
2. Rubenstein JH and Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015; 149:302-317.e301.
3. B Ef and Thorburn A. Recent insights into cell death and autophagy. The FEBS journal. 2015.
4. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, Penninger J, et al. Autophagy in malignant transformation and cancer progression. The EMBO journal. 2015; 34:856-880.
5. Janji B, Viry E, Moussay E, Paggetti J, Arakelian T, Mgrditchian T, Messai Y, Noman MZ, Van Moer K, Hasmim M, Mami-Chouaib F, Berchem G and Chouaib S. The multifaceted role of autophagy in tumor evasion from immune surveillance. Oncotarget. 2016; doi: 10.18632/oncotarget.7540.
6. Pan H, Chen L, Xu Y, Han W, Lou F, Fei W, Liu S, Jing Z and Sui X. Autophagy-associated immune responses and cancer immunotherapy. Oncotarget. 2016; doi: 10.18632/oncotarget.6908.
7. Mandelbaum J, Rollins N, Shah P, Bowman D, Lee JY, Tayber O, Bernard H, LeRoy P, Li P, Koenig E, Brownell JE and D'Amore N. Identification of a lung cancer cell line deficient in atg7-dependent autophagy. Autophagy. 2015:0.
8. Ouyang DY, Xu LH, He XH, Zhang YT, Zeng LH, Cai JY and Ren S. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5. Autophagy. 2013; 9:20-32.
9. Jiang P and Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods (San Diego, Calif). 2015; 75:13-18.
10. Schlafli AM, Berezowska S, Adams O, Langer R and Tschan MP. Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry. European journal of histochemistry. 2015; 59:2481.
11. Sobin L, Gospodarowicz M and Wittekind C. (2010). TNM classification of malignant tumors. (New York: John Wiley & Sons).
12. Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D and Inazawa J. High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer. The American journal of pathology. 2015; 185:2523-2533.
13. Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu YC and Hung CH. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. British journal of cancer. 2014; 111:944-954.
14. Deretic V, Jiang S and Dupont N. Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends in cell biology. 2012; 22:397-406.
15. Lapaquette P, Guzzo J, Bretillon L and Bringer MA. Cellular and Molecular Connections between Autophagy and Inflammation. Mediators of inflammation. 2015; 2015:398483.
16. O'Donovan TR, O'Sullivan GC and McKenna SL. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy. 2011; 7:509-524.
17. O'Donovan TR, Rajendran S, O'Reilly S, O'Sullivan GC and McKenna SL. Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo. PloS one. 2015; 10:e0134676.
18. Roesly HB, Khan MR, Chen HD, Hill KA, Narendran N, Watts GS, Chen X and Dvorak K. The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. American journal of physiology Gastrointestinal and liver physiology. 2012; 302:G864-872.
19. El-Mashed S, O'Donovan TR, Kay EW, Abdallah AR, Cathcart MC, O'Sullivan J, O'Grady A, Reynolds J, O'Reilly S, O'Sullivan GC and McKenna SL. LC3B globular structures correlate with survival in esophageal adenocarcinoma. BMC cancer. 2015; 15:582.
20. Martinet W, Schrijvers DM, Timmermans JP, Bult H and De Meyer GR. Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy. 2013; 9:386-402.
21. He H, Dang Y, Dai F, Guo Z, Wu J, She X, Pei Y, Chen Y, Ling W, Wu C, Zhao S, Liu JO and Yu L. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. The Journal of biological chemistry. 2003; 278:29278-29287.
22. Wu J, Dang Y, Su W, Liu C, Ma H, Shan Y, Pei Y, Wan B, Guo J and Yu L. Molecular cloning and characterization of rat LC3A and LC3B-two novel markers of autophagosome. Biochemical and biophysical research communications. 2006; 339:437-442.
23. Bao L, Chandra PK, Moroz K, Zhang X, Thung SN, Wu T and Dash S. Impaired autophagy response in human hepatocellular carcinoma. Experimental and molecular pathology. 2014; 96:149-154.
24. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, Sasano H, Nakagawa T, Satoh K, Tanaka N, Kubo H, Motohashi H, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer science. 2012; 103:760-766.
25. Mohamed A, Ayman A, Deniece J, Wang T, Kovach C, Siddiqui MT and Cohen C. P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas. Frontiers in oncology. 2015; 5:70.
26. Ren F, Shu G, Liu G, Liu D, Zhou J, Yuan L and Zhou J. Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth. Molecular and cellular biochemistry. 2014; 385:95-102.
27. Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T and Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer science. 2015; 106:1-8.
28. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007; 131:1149-1163.
29. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT and Moscat J. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer cell. 2008; 13:343-354.
30. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC and Chiao PJ. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer cell. 2012; 21:105-120.
31. Moscat J and Diaz-Meco MT. p62: a versatile multitasker takes on cancer. Trends in biochemical sciences. 2012; 37:230-236.
32. Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T, Fu W, Zhang J, Wu W, Zhang X and Chen YG. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nature cell biology. 2010; 12:781-790.
33. Kuo TC, Chen CT, Baron D, Onder TT, Loewer S, Almeida S, Weismann CM, Xu P, Houghton JM, Gao FB, Daley GQ and Doxsey S. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nature cell biology. 2011; 13:1214-1223.
34. Linares JF, Amanchy R, Greis K, Diaz-Meco MT and Moscat J. Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Molecular and cellular biology. 2011; 31:105-117.
35. Rello-Varona S, Lissa D, Shen S, Niso-Santano M, Senovilla L, Marino G, Vitale I, Jemaa M, Harper F, Pierron G, Castedo M and Kroemer G. Autophagic removal of micronuclei. Cell cycle (Georgetown, Tex). 2012; 11:170-176.
36. Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G and Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. The Journal of biological chemistry. 2010; 285:5941-5953.
37. Dagda RK, Zhu J, Kulich SM and Chu CT. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy. 2008; 4:770-782.
38. Zlobec I, Koelzer VH, Dawson H, Perren A and Lugli A. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. Journal of translational medicine. 2013; 11:104.
39. Brown M, Sillah K, Griffiths EA, Swindell R, West CM, Page RD, Welch IM and Pritchard SA. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology. 2010; 56:893-899.